SHS appoints senior manager

SHS Gesellschaft für Beteiligungsmanagement, a German biotech company, has recruited Stephan Rapp as a new senior manager. A financial analyst with a doctorate in biochemistry, Rapp joins from the Bavarian Red Cross, where he was a managing director in the business development department.

In his new role, he will support the development of young portfolio companies at the in the areas of life sciences and healthcare.

Before the Red Cross, Rapp was manager of clinical operations at the Genetics Institute, the biotech division of Wyeth, and prior to this was a project manager of clinical research at Fujisawa, and a scientist at the biochemical centre in Heidelberg and the German cancer research centre.